Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)

NCT03013218

Conditions
Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • University of Colorado Denver Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers

NCT04306900

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +34 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Clinical Trials Office Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 32 locations
View Trial Details
Completed

Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

NCT04300790

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital Universitari Vall D'Hebron Barcelona, Spain
  • Institut Català d' Oncologia L'Hospitalet (ICO) Barcelona, Spain
  • Hospital Universitario de Basurto Bilbao, Spain
View all 19 locations
View Trial Details
Completed

DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease

NCT04420598

Conditions
Advanced Breast Cancer, Brain Diseases, Brain Metastases, +19 more
Locations
  • Champalimaud Center for the Unknown Lisbon, Portugal
  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE (IPO Porto) Porto, Portugal
  • Institut Català d'Oncologica ICO Badalona Badalona, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
View all 16 locations
View Trial Details

Related conditions